Deborah M. Choquette

686 total citations
13 papers, 237 citations indexed

About

Deborah M. Choquette is a scholar working on Organic Chemistry, Molecular Biology and Hepatology. According to data from OpenAlex, Deborah M. Choquette has authored 13 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Hepatology. Recurrent topics in Deborah M. Choquette's work include Organometallic Complex Synthesis and Catalysis (3 papers), Liver physiology and pathology (3 papers) and Acute Myeloid Leukemia Research (2 papers). Deborah M. Choquette is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (3 papers), Liver physiology and pathology (3 papers) and Acute Myeloid Leukemia Research (2 papers). Deborah M. Choquette collaborates with scholars based in United States, Switzerland and Italy. Deborah M. Choquette's co-authors include Roy P. Planalp, Jean-Christophe Harmange, Yohannes Teffera, Marilyn M. Olmstead, Kazi J. Ahmed, Wayne E. Buschmann, Yajing Yang, Christiane Bode, Anthony Polverino and Martin A. Broome and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Inorganic Chemistry.

In The Last Decade

Deborah M. Choquette

13 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah M. Choquette United States 10 106 85 55 48 42 13 237
Shiming Fan China 8 143 1.3× 127 1.5× 29 0.5× 39 0.8× 60 1.4× 36 317
Kenneth J. Wiggall United States 9 199 1.9× 104 1.2× 25 0.5× 56 1.2× 11 0.3× 10 362
Hirotaka Kashiwagi Japan 10 189 1.8× 44 0.5× 53 1.0× 76 1.6× 36 0.9× 21 450
Rajeev S. Bhide United States 13 234 2.2× 217 2.6× 18 0.3× 96 2.0× 38 0.9× 19 461
Donna Wei United States 12 146 1.4× 140 1.6× 17 0.3× 35 0.7× 49 1.2× 14 375
Xintian Wang China 8 105 1.0× 46 0.5× 56 1.0× 199 4.1× 36 0.9× 12 285
Guangxiu Dai China 7 603 5.7× 126 1.5× 49 0.9× 30 0.6× 38 0.9× 22 737
Celedonio Gómez-Ruíz Mexico 9 111 1.0× 111 1.3× 70 1.3× 235 4.9× 32 0.8× 10 379
Zhen‐Wei Cai United States 10 168 1.6× 148 1.7× 9 0.2× 58 1.2× 21 0.5× 14 339
Lukas Fiebig Germany 9 97 0.9× 48 0.6× 37 0.7× 28 0.6× 9 0.2× 13 220

Countries citing papers authored by Deborah M. Choquette

Since Specialization
Citations

This map shows the geographic impact of Deborah M. Choquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah M. Choquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah M. Choquette more than expected).

Fields of papers citing papers by Deborah M. Choquette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah M. Choquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah M. Choquette. The network helps show where Deborah M. Choquette may publish in the future.

Co-authorship network of co-authors of Deborah M. Choquette

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah M. Choquette. A scholar is included among the top collaborators of Deborah M. Choquette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah M. Choquette. Deborah M. Choquette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hughes, Paul E., Karen Rex, Sean Caenepeel, et al.. (2016). In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models. Molecular Cancer Therapeutics. 15(7). 1568–1579. 44 indexed citations
2.
Hughes, Paul E., Yajing Yang, Karen Rex, et al.. (2014). Abstract 728: AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models. Cancer Research. 74(19_Supplement). 728–728. 6 indexed citations
3.
Bode, Christiane, Alessandro A. Boezio, Brian K. Albrecht, et al.. (2012). Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4089–4093. 16 indexed citations
4.
Heidary, David K., George Q. Huang, Diane M. Boucher, et al.. (2012). VX-322: A Novel Dual Receptor Tyrosine Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry. 55(2). 725–734. 15 indexed citations
5.
Wilcoxen, Keith, Rachael Brake, Yohannes Teffera, et al.. (2012). Abstract 1795: Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase. Cancer Research. 72(8_Supplement). 1795–1795. 10 indexed citations
6.
Lewis, Richard T., Christiane Bode, Deborah M. Choquette, et al.. (2012). The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer. Journal of Medicinal Chemistry. 55(14). 6523–6540. 38 indexed citations
7.
Davies, Robert J.O., Albert C. Pierce, Cornelia J. Forster, et al.. (2011). Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry. 54(20). 7184–7192. 18 indexed citations
8.
Teffera, Yohannes, Deborah M. Choquette, Jingzhou Liu, et al.. (2010). Bioactivation of Isothiazoles: Minimizing the Risk of Potential Toxicity in Drug Discovery. Chemical Research in Toxicology. 23(11). 1743–1752. 6 indexed citations
9.
Choquette, Deborah M., Yohannes Teffera, Anthony Polverino, & Jean-Christophe Harmange. (2008). Discovery of novel 1,2,3,4-tetrahydroisoquinolines and 3,4-dihydroisoquinoline-1(2H)-ones as potent and selective inhibitors of KDR: Synthesis, SAR, and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 18(14). 4054–4058. 16 indexed citations
10.
Choquette, Deborah M., Wayne E. Buschmann, Russell F. Graceffa, & Roy P. Planalp. (1995). Synthesis and reactivity of cyclopentadienyltitanium complexes of the polydentate alkoxide ligand cis-1,3,5-cyclohexanetrialkoxide. Polyhedron. 14(17-18). 2569–2573. 2 indexed citations
11.
Choquette, Deborah M., Wayne E. Buschmann, Marilyn M. Olmstead, & Roy P. Planalp. (1993). Synthesis, structure, and alcoholysis of .eta.5-1,3-bis(trimethylsilyl)cyclopentadienyltitanium cis-1,3,5-cyclohexanetrialkoxide, an adamantane-framework complex of a polydentate alkoxide ligand. Inorganic Chemistry. 32(7). 1062–1063. 14 indexed citations
12.
Choquette, Deborah M., et al.. (1993). Thermolysis of halo- and alkylaluminum silylamido complexes and the Al4N4 cubane core structure of [iso-BuAlNSiPh3]4. Inorganic Chemistry. 32(11). 2600–2603. 17 indexed citations
13.
Choquette, Deborah M., et al.. (1992). Syntheses, structures, and isomerization processes of dialkylaluminum silylamido complexes. Organometallics. 11(2). 529–534. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026